19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Targeting transcription factor STAT3 for cancer prevention and therapy.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Signal Transducers and Activators of Transcription (STATs) comprise an important class of transcription factors that have been implicated in a wide variety of essential cellular functions related to proliferation, survival, and angiogenesis. Among various STAT members, STAT3 is frequently overexpressed in tumor cells as well as tissue samples, and regulates the expression of numerous oncogenic genes controlling the growth and metastasis of tumor cells. The current review briefly discusses the importance of STAT3 as a potential target for cancer therapy and also provides novel insights into various classes of existing pharmacological inhibitors of this transcription factor that can be potentially developed as anti-cancer drugs.

          Related collections

          Author and article information

          Journal
          Pharmacol. Ther.
          Pharmacology & therapeutics
          Elsevier BV
          1879-016X
          0163-7258
          Jun 2016
          : 162
          Affiliations
          [1 ] Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
          [2 ] School of Biomedical Sciences, CHIRI Biosciences Research Precinct, Curtin University, WA 6009, Australia.
          [3 ] Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Cancer Science Institute of Singapore, Centre for Translational Medicine, 14 Medical Drive, #11-01M, Singapore 117599.
          [4 ] Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; School of Biomedical Sciences, CHIRI Biosciences Research Precinct, Curtin University, WA 6009, Australia; Cancer Science Institute of Singapore, Centre for Translational Medicine, 14 Medical Drive, #11-01M, Singapore 117599; Department of Biological Sciences, University of North Texas, Denton, TX 76203, United States.
          [5 ] Department of Physiology, Centre for Life Sciences, NUHS, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117456.
          [6 ] Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Cancer Science Institute of Singapore, Centre for Translational Medicine, 14 Medical Drive, #11-01M, Singapore 117599; Department of Haematology-Oncology, National University Health System, Singapore 117597.
          [7 ] College of Korean Medicine, Kyung Hee University, Kyungheedae-gil, Dongdaemoon-gu, Seoul 130-701, Republic of Korea.
          [8 ] Division of Cellular and Molecular Research, Humphrey Oei Institute of Cancer Research, National Cancer Centre, Singapore 169610.
          [9 ] Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; School of Biomedical Sciences, CHIRI Biosciences Research Precinct, Curtin University, WA 6009, Australia. Electronic address: phcgs@nus.edu.sg.
          Article
          S0163-7258(15)00185-0
          10.1016/j.pharmthera.2015.10.004
          26478441
          f220d6a4-633f-433e-a329-d987b1c9f781
          History

          Angiogenesis,Apoptosis,Cancer,Cytokines,Proliferation,STAT3
          Angiogenesis, Apoptosis, Cancer, Cytokines, Proliferation, STAT3

          Comments

          Comment on this article